From: Gene expression profile of placentomes and clinical parameters in the cows with retained placenta
Enriched biological processes and their associated genes | Enrichment ratio | PÂ value |
---|---|---|
Glucosylceramide metabolic process FA2H, UGCG | 60.2 | 0.000403 |
Response to platelet aggregation inhibitor GNAI1, FDX1 | 40.133 | 0.000997 |
Fatty acid metabolic process ACSL1, SLC27A6, PLA2G15, FA2H, FASN, PDK1, CPT1A, HACD2, ACOX1 | 6.7304 | 6.29E-06 |
Monocarboxylic acid metabolic process CYP1A2, ACSL1, SLC27A6, ATP8B1, PLA2G15, FA2H, FASN, PDK1, CPT1A, HACD2, ACOX1 | 5.1734 | 6.92E-06 |
Oxoacid metabolic process CYP1A2, GLCE, ACSL1, SLC27A6, ATP8B1, OAT, PLA2G15, AASS, FA2H, BCAT1, FASN, PDK1, CPT1A, HACD2, ACOX1 | 3.6857 | 8.1E-06 |
Organic acid metabolic process CYP1A2, GLCE, ACSL1, SLC27A6, ATP8B1, OAT, PLA2G15, AASS, FA2H, BCAT1, FASN, PDK1, CPT1A, HACD2, ACOX1 | 3.612 | 1.03E-05 |
Carboxylic acid metabolic process CYP1A2, ACSL1, SLC27A6, ATP8B1, OAT, PLA2G15, AASS, FA2H, BCAT1, FASN, PDK1, CPT1A, HACD2, ACOX1 | 3.6017 | 2.23E-05 |
Cellular lipid metabolic process CYP1A2, ACSL1, SLC27A6, PLA2G15, FA2H, FASN, UGCG, PDK1, PLD1, CPT1A, HACD2, ACOX1 | 3.1965 | 0.000291 |
Lipid metabolic process CYP1A2, ACSL1, SLC27A6, ATP8B1, PLA2G15, FDX1, FA2H, FASN, UGCG, PDK1, PLD1, CPT1A, HACD2, ACOX1 | 2.8473 | 0.000283 |
Small molecule metabolic process CYP1A2, GLCE, AHCYL2, ACSL1, SLC27A6, ATP8B1, OAT, PLA2G15, ACPP, FDX1, AASS, FA2H, BCAT1, FASN, PDK1, PDXK, CPT1A, EPM2AIP1, HACD2, ACOX1 | 2.5536 | 4.69E-05 |